Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Teva welcomes EMET Prize win for Azilect scientist

Teva welcomes EMET Prize win for Azilect scientist

20th January 2011

Teva has welcomed the news that a scientist who played a key role in the development of its Parkinson's therapy Azilect has won an EMET Prize.

Professor Moussa Youdim has been presented with the Life Sciences 2010 EMET Prize for Brain Sciences by the AMN Foundation for the Advancement of Science, Art and Culture in Israel.

It was awarded in honour of his achievements in the field of neurological studies, including his research into the function of the enzymes monoamine oxidase A and B in the brain, which formed the basis of Azilect's creation.

Teva's drug has since been launched in 45 countries around the world, with clinical research suggesting it may help to slow the progression of the neurodegenerative illness.

Professor Youdim said: "I look forward to seeing the continued role Azilect research may play in supporting advancements in the treatment of Parkinson's disease."

Earlier this month, Teva announced the completion of its takeover of Theramex, a women's health business unit formerly owned by Merck Serono.ADNFCR-8000103-ID-800354958-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.